What's new in antifungals: An update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents

Nathan P. Wiederhold; Thomas F. Patterso

doi:10.1097/QCO.0000000000000203

What's new in antifungals: An update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents

Nathan P. Wiederhold, Thomas F. Patterso

Research output: Contribution to journal › Review article › peer-review

17 Scopus citations

Abstract

Several new antifungal agents are currently in various stages of development. This is promising, as there is a continued need for new agents to treat invasive fungal infections. Which ones will receive approval for clinical use and their impact in patients with these infections remain unknown.

Original language	English (US)
Pages (from-to)	539-546
Number of pages	8
Journal	Current Opinion in Infectious Diseases
Volume	28
Issue number	6
DOIs	https://doi.org/10.1097/QCO.0000000000000203
State	Published - Nov 3 2015

Keywords

Aspergillus
Candida
antifungal resistance
invasive fungal infections
investigational antifungals

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1097/QCO.0000000000000203

Cite this

@article{7c9ce02bf6804a6ba3c9f1c0962ec2a8,

title = "What's new in antifungals: An update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents",

abstract = "Several new antifungal agents are currently in various stages of development. This is promising, as there is a continued need for new agents to treat invasive fungal infections. Which ones will receive approval for clinical use and their impact in patients with these infections remain unknown.",

keywords = "Aspergillus, Candida, antifungal resistance, invasive fungal infections, investigational antifungals",

author = "Wiederhold, {Nathan P.} and Patterso, {Thomas F.}",

year = "2015",

month = nov,

day = "3",

doi = "10.1097/QCO.0000000000000203",

language = "English (US)",

volume = "28",

pages = "539--546",

journal = "Current Opinion in Infectious Diseases",

issn = "0951-7375",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - What's new in antifungals

T2 - An update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents

AU - Wiederhold, Nathan P.

AU - Patterso, Thomas F.

PY - 2015/11/3

Y1 - 2015/11/3

N2 - Several new antifungal agents are currently in various stages of development. This is promising, as there is a continued need for new agents to treat invasive fungal infections. Which ones will receive approval for clinical use and their impact in patients with these infections remain unknown.

AB - Several new antifungal agents are currently in various stages of development. This is promising, as there is a continued need for new agents to treat invasive fungal infections. Which ones will receive approval for clinical use and their impact in patients with these infections remain unknown.

KW - Aspergillus

KW - Candida

KW - antifungal resistance

KW - invasive fungal infections

KW - investigational antifungals

UR - http://www.scopus.com/inward/record.url?scp=84947017165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947017165&partnerID=8YFLogxK

U2 - 10.1097/QCO.0000000000000203

DO - 10.1097/QCO.0000000000000203

M3 - Review article

C2 - 26374950

AN - SCOPUS:84947017165

SN - 0951-7375

VL - 28

SP - 539

EP - 546

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

IS - 6

ER -

What's new in antifungals: An update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this